Rui Cui

8PUBLICATIONS
20CO-AUTHORS
Predictive and prognostic markersHaematological tumoursLiquid biopsiesCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Sep 21, 2026
Exploring CAR-T Resistance Mechanisms in Relapsed/Refractory DLBCL via Integrated Histopathological and Transcriptomic Profiling.

|Jul 30, 2026
Pretreatment With BTK Inhibitors Improved the Sensitivity of DLBCL Cells to CAR-T Cells in a Coculture System by Downregulating the Polarisation of M2 Macrophages.

|Dec 15, 2025
Thiotepa and Busulfan Combined With Cyclophosphamide Conditioning Regimen Plus Maintenance Therapy Improved the Disease-Free Survival of Patients With Relapsed/Refractory Hematologic Malignancies After Undergoing Allogeneic Transplantation.

Shulian Chen, Rui Cui, Yi He

|Sep 22, 2025
COVID-19 Infection Confirmed by Bronchoalveolar Lavage Fluid Metagenomics -Next-Generation Sequencing Instead of Pharyngeal Swabs in Follicular Lymphoma: Three-Case Report and Literature Review.

Can Liu, Yupeng Song, Siyan Niu

|Apr 28, 2025
De novo AML spontaneously achieved PR after COVID-19 infection, and CR after reduced dose of azacytidine combined with venetoclax: A case report and literature review.

Yao Qi, Jing-Yi Li, Jia Wang

|Dec 23, 2021
Efficacy and follow-up of humanized anti-BCMA CAR-T cell therapy in relapsed/refractory multiple myeloma patients with extramedullary-extraosseous, extramedullary-bone related, and without extramedullary disease.

Wei Li, Meijing Liu, Ting Yuan

Pageof 2

Frequent Collaborators

4 joint publications

Qi Deng

2 joint publications

Xin Li

1 joint publications

Wei Li

1 joint publications

Ying Yu